Kenon Holdings Reports Strong 2025 Results, Declares $200M Dividend, and Subsidiary Raises $257M

summarizeSummary

Kenon Holdings Ltd. announced strong full-year 2025 financial results, including a significant increase in profit from continuing operations, and declared a substantial $200 million cash dividend. Its subsidiary, OPC, also completed a $257 million private placement.

check_boxKey Events

• Strong Full-Year 2025 Financial Results

  Kenon Holdings reported a significant increase in profit from continuing operations to $148 million in 2025, up from $53 million in 2024. Its subsidiary, OPC, more than doubled its net profit to $132 million and saw Adjusted EBITDA rise to $457 million.

• Substantial Cash Dividend Declared

  The board of directors approved a cash dividend of $3.85 per share, totaling approximately $200 million, payable in April 2026. This represents a significant return of capital to shareholders.

• Subsidiary Completes Private Placement

  OPC, Kenon's primary subsidiary, successfully issued new shares in a private placement, raising approximately $257 million (NIS 800 million) to support its operations and growth.

• ZIM Derivative Position Settled

  Kenon cash settled its capped call arrangement over five million ZIM shares in Q1 2026, generating gross proceeds of approximately $34 million and marking its full exit from ZIM-related derivative instruments.

auto_awesomeAnalysis

Kenon Holdings Ltd. reported robust financial performance for 2025, with profit from continuing operations significantly increasing. This positive operational momentum is further underscored by the board's approval of a substantial $200 million cash dividend, representing a significant return of capital to shareholders. Additionally, its primary subsidiary, OPC, successfully raised approximately $257 million through a private placement, which is expected to support its growth initiatives. The settlement of the ZIM capped call arrangement also provides additional liquidity and finalizes the company's exit from ZIM-related derivatives.